Form 4: Avanos Medical SVP Disposes Shares for Tax Obligations

Sigfrido Delgado, SVP of Operations at Avanos Medical, surrendered 4,264 shares to cover tax liabilities following the vesting of restricted stock units.

Summary

• Sigfrido Delgado, Senior Vice President of Operations, reported a transaction involving Avanos Medical (AVNS) common stock on April 22, 2026.
• The transaction involved the vesting of 16,300 time-based restricted share units (TRSUs) that were originally awarded on April 22, 2025.
• A total of 4,264 shares were surrendered to the company to satisfy tax withholding obligations triggered by the vesting.
• The shares were disposed of at a price of 24.64 per share, representing a total value of approximately 105,065.
• Following this transaction, Delgado maintains a direct ownership of 55,741 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing. It reflects standard executive compensation mechanics with no impact on company fundamentals.

Positives

• The reporting person retains a significant ownership stake of 55,741 shares, aligning executive interests with shareholders.
• The disposal was a routine 'surrender to cover' for taxes rather than an open-market sale, suggesting no lack of confidence in the company.
• Successful completion of a one-year service milestone for the vesting of 16,300 restricted share units.

Negatives

• The transaction resulted in a decrease of 4,264 shares from the executive's total potential holding.

Risks

• Executive stock disposals, even for tax purposes, can occasionally be misinterpreted by the market as a signal of peak valuation.
• Future share price volatility could impact the perceived value of executive compensation and retention incentives.

Future Outlook

The filing does not provide specific forward-looking guidance or financial forecasts for the company.

Management Comments

• The reporting person surrendered shares to satisfy tax withholding obligations upon the vesting of 16,300 time-based restricted share units.

Industry Context

StockSavvy.ai notes that tax-related share surrenders are standard administrative procedures for executives in the medical technology sector and typically do not reflect a change in corporate outlook or fundamental business health.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) with one-year vesting tranches is consistent with compensation structures at peer medical device companies like Merit Medical Systems and Teleflex.
• Surrendering shares for tax withholding is the most common method for executives to handle vestings, avoiding the need for out-of-pocket cash payments.

Related Party Transactions

• The transaction itself is a related party transaction between the SVP of Operations and the Issuer regarding equity compensation.

Stakeholder Impact

• Minimal impact on shareholders as the transaction does not involve an open-market sale and represents a small fraction of total shares outstanding.

Next Steps

• No future actions or milestones were mentioned in this specific ownership filing.

Key Dates

Recommendation

This filing is a routine disclosure of insider activity related to compensation and does not provide a catalyst for changing an investment thesis. Investors should maintain their current positions pending more substantive operational or financial updates.

Keywords

Avanos Medical, AVNS, Insider Trading, Form 4, Sigfrido Delgado, Restricted Stock Units, Executive Compensation, Medical Devices